The Immunohistochemical Expression of Epithelial–Mesenchymal Transition Markers in Precancerous Lesions and Cervical Cancer
International Journal of Molecular Sciences · 29.04.2023 · 24 (9) · 8063
DOI: 10.3390/ijms24098063 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.04.2023. Verfasst von Aneta Popiel-Kopaczyk und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, 50-368 Wroclaw, Poland. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Uterine Cervical Dysplasia. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center, National Science Centre.
Abstract (Originalsprache)
In the epithelial–mesenchymal transition (EMT) process, cells lose their epithelial phenotype and gain mesenchymal features. This phenomenon was observed in the metastatic phase of neoplastic diseases, e.g., cervical cancer. There are specific markers that are expressed in the EMT. The aim of this study was to determine the localization of and associations between the immunohistochemical (IHC) expression of TWIST, SNAIL, and SLUG proteins in precancerous lesions and cervical cancer. The IHC analysis disclosed higher expressions of EMT markers in precancerous lesions and cervical cancer than in the control group. Moreover, stronger expression of TWIST, SNAIL, and SLUG was observed in cervical intraepithelial neoplasia grade 3 (CIN3) vs. CIN1, CIN3 vs. CIN2, and CIN2 vs. CIN1 cases (p < 0.05). In cervical cancer, IHC reactions demonstrated differences in TWIST, SNAIL, and SLUG expression in grade 1 (G1) vs. grade 2 (G2) (p < 0.0011; p < 0.0017; p < 0.0001, respectively) and in G1 vs. grade 3 (G3) (p < 0.0029; p < 0.0005; p < 0.0001, respectively). The results of our study clearly showed that existing differences in the expression of the tested markers in precancerous vs. cancerous lesions may be utilized in the diagnosis of cervical cancer. Further studies on bigger populations, as well as in comparison with well-known markers, may improve our outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, 50-368 Wroclaw, Poland.
- Division of Anatomy, Department of Human Morphology and Embryology, Wroclaw Medical University, 50-368 Wroclaw, Poland.
- Department of Pathology, Polish Mother's Memorial Hospital Research Institute, 93-338 Lodz, Poland.
- Department of Physiotherapy, University School of Physical Education, 51-612 Wroclaw, Poland.
- Division of Ultrastructural Research, Wroclaw Medical University, 50-368 Wroclaw, Poland.
ORCID-Profile: Aneta Popiel-Kopaczyk, Aleksandra Piotrowska, Beata Smolarz, Christopher Kobierzycki
Förderung
- National Science Center
- National Science Centre
Zitieren
APA
Popiel-Kopaczyk, A., Piotrowska, A., Sputa-Grzegrzolka, P., Smolarz, B., Romanowicz, H., Dziegiel, P., Podhorska-Okolow, M., & Kobierzycki, C. (2023). The Immunohistochemical Expression of Epithelial–Mesenchymal Transition Markers in Precancerous Lesions and Cervical Cancer. International Journal of Molecular Sciences, 24(9), 8063. https://doi.org/10.3390/ijms24098063
Vancouver
Popiel-Kopaczyk A, Piotrowska A, Sputa-Grzegrzolka P, Smolarz B, Romanowicz H, Dziegiel P, et al. The Immunohistochemical Expression of Epithelial–Mesenchymal Transition Markers in Precancerous Lesions and Cervical Cancer. International Journal of Molecular Sciences. 2023;24(9):8063. doi:10.3390/ijms24098063
BibTeX
@article{PopielKopaczyk2023,
author = {Popiel-Kopaczyk, Aneta and Piotrowska, Aleksandra and Sputa-Grzegrzolka, Patrycja and Smolarz, Beata and Romanowicz, Hanna and Dziegiel, Piotr and Podhorska-Okolow, Marzenna and Kobierzycki, Christopher},
title = {The Immunohistochemical Expression of Epithelial–Mesenchymal Transition Markers in Precancerous Lesions and Cervical Cancer},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {9},
pages = {8063},
doi = {10.3390/ijms24098063}
}
EUVIMED